These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
460 related items for PubMed ID: 9153548
1. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Lundberg I, Ulfgren AK, Nyberg P, Andersson U, Klareskog L. Arthritis Rheum; 1997 May; 40(5):865-74. PubMed ID: 9153548 [Abstract] [Full Text] [Related]
2. New developments in the role of cytokines and chemokines in inflammatory myopathies. Lundberg IE, Nyberg P. Curr Opin Rheumatol; 1998 Nov; 10(6):521-9. PubMed ID: 9812212 [Abstract] [Full Text] [Related]
3. Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls. Lundberg I, Brengman JM, Engel AG. J Neuroimmunol; 1995 Dec; 63(1):9-16. PubMed ID: 8557829 [Abstract] [Full Text] [Related]
4. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes. Authier FJ, Mhiri C, Chazaud B, Christov C, Cherin P, Barlovatz-Meimon G, Gherardi RK. Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898 [Abstract] [Full Text] [Related]
5. Local expression of cytokines in idiopathic inflammatory myopathies. Lepidi H, Frances V, Figarella-Branger D, Bartoli C, Machado-Baeta A, Pellissier JF. Neuropathol Appl Neurobiol; 1998 Feb; 24(1):73-9. PubMed ID: 9549732 [Abstract] [Full Text] [Related]
6. The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies. Lundberg IE. Curr Rheumatol Rep; 2000 Jun; 2(3):216-24. PubMed ID: 11123062 [Abstract] [Full Text] [Related]
7. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies. Grundtman C, Salomonsson S, Dorph C, Bruton J, Andersson U, Lundberg IE. Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504 [Abstract] [Full Text] [Related]
8. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis. Sallum AM, Kiss MH, Silva CA, Wakamatsu A, Vianna MA, Sachetti S, Marie SK. Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335 [Abstract] [Full Text] [Related]
9. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis. Lundberg I, Kratz AK, Alexanderson H, Patarroyo M. Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873 [Abstract] [Full Text] [Related]
10. Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies. Illa I, Gallardo E, Gimeno R, Serrano C, Ferrer I, Juárez C. Am J Pathol; 1997 Jul; 151(1):81-8. PubMed ID: 9212734 [Abstract] [Full Text] [Related]
11. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Choi YC, Dalakas MC. Neurology; 2000 Jan 11; 54(1):65-71. PubMed ID: 10636127 [Abstract] [Full Text] [Related]
12. Interleukin-35 in idiopathic inflammatory myopathies. Mann H, Kryštůfková O, Zámečník J, Háček J, Hulejová H, Filková M, Vencovský J, Šenolt L. Cytokine; 2021 Jan 11; 137():155350. PubMed ID: 33128920 [Abstract] [Full Text] [Related]
13. Dual effects of caspase-1, interleukin-1 beta, tumour necrosis factor-alpha and nerve growth factor receptor in inflammatory myopathies. Mackiewicz Z, Hukkanen M, Povilenaite D, Sukura A, Fonseca JE, Virtanen I, Konttinen YT. Clin Exp Rheumatol; 2003 Jan 11; 21(1):41-8. PubMed ID: 12673888 [Abstract] [Full Text] [Related]
14. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies. De Paepe B, De Keyzer K, Martin JJ, De Bleecker JL. Acta Neuropathol; 2005 Jun 11; 109(6):576-82. PubMed ID: 15937690 [Abstract] [Full Text] [Related]
15. The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositis. Lu X, Tang Q, Lindh M, Dastmalchi M, Alexanderson H, Popovic Silwerfeldt K, Agerberth B, Lundberg IE, Wick C. J Autoimmun; 2017 Mar 11; 78():46-56. PubMed ID: 28012697 [Abstract] [Full Text] [Related]
16. Role of cytokines and chemokines in idiopathic inflammatory myopathies. De Paepe B, Creus KK, De Bleecker JL. Curr Opin Rheumatol; 2009 Nov 11; 21(6):610-6. PubMed ID: 19726994 [Abstract] [Full Text] [Related]
17. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages. De Paepe B, Creus KK, Martin JJ, Weis J, De Bleecker JL. Ann N Y Acad Sci; 2009 Sep 11; 1173():463-9. PubMed ID: 19758187 [Abstract] [Full Text] [Related]
18. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Dastmalchi M, Grundtman C, Alexanderson H, Mavragani CP, Einarsdottir H, Helmers SB, Elvin K, Crow MK, Nennesmo I, Lundberg IE. Ann Rheum Dis; 2008 Dec 11; 67(12):1670-7. PubMed ID: 18272672 [Abstract] [Full Text] [Related]
19. Transforming growth factor-beta 1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate. Confalonieri P, Bernasconi P, Cornelio F, Mantegazza R. J Neuropathol Exp Neurol; 1997 May 11; 56(5):479-84. PubMed ID: 9143260 [Abstract] [Full Text] [Related]
20. Downregulation of TGF-beta1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin. Amemiya K, Semino-Mora C, Granger RP, Dalakas MC. Clin Immunol; 2000 Feb 11; 94(2):99-104. PubMed ID: 10637094 [Abstract] [Full Text] [Related] Page: [Next] [New Search]